Design and testing of peptide-based cytotoxic T-cell-mediated immunotherapeutics to treat infectious diseases and cancer.
Chesnut
R W
RW
Cytel Corporation, San Diego, California 92121, USA.
Sette
A
A
Celis
E
E
Wentworth
P
P
Kubo
R T
RT
Alexander
J
J
Ishioka
G
G
Vitiello
A
A
Grey
H M
HM
D000818:Animals; D015195:Drug Design; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology*; D007167:Immunotherapy; D007239:Infections / Q000628:therapy*; D009369:Neoplasms / Q000628:therapy*; D010455:Peptides / Q000138:chemical synthesis / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D010455:Peptides